Clinical trial NCT06168838 - References

Intracranial Hemorrhages — Anticoagulant-associated Intracranial Hemorrhage

Citation(s)

•   Adachi T, Hoshino H, Takagi M, Fujioka S; Saiseikai Stroke Research Group
  Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin . Cerebrovasc Dis Extra. 2017;7(1):62-71. doi: 10.1159/000462985.
•   Ballestri S, Romagnoli E, Arioli D, Coluccio V, Marrazzo A, Athanasiou A, Di Girolamo M, Cappi C, Marietta M, Capitelli M
  Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromb
•   Barrios V, Cinza-Sanjurjo S, Gavin O, Egocheaga I, Burgos-Pol R, Soto J, Polanco C, Suarez J, Casado MA
  Cost and burden of poor anticoagulation control with vitamin K antagonists in patients with nonvalvular atrial fibrillation in Spain. Rev Esp Cardiol
•   Deitelzweig S, Neuman WR, Lingohr-Smith M, Menges B, Lin J
  Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. J Med Econ. 2017 Dec;20(12):1217-1223. doi: 10.1080/13696998.2017.
•   Flaherty ML
  Anticoagulant-associated intracerebral hemorrhage. Semin Neurol. 2010 Nov;30(5):565-72. doi: 10.1055/s-0030-1268866. Epub 2011 Jan 4.
•   Grysiewicz R, Gorelick PB
  Incidence, mortality, and risk factors for oral anticoagulant-associated intracranial hemorrhage in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2479-2488. doi: 10.1016/j.jstrokecerebrovasdis.
•   Hellenbart EL, Faulkenberg KD, Finks SW
  Evaluation of bleeding in patients receiving direct oral anticoagulants. Vasc Health Risk Manag. 2017 Aug 23;13:325-342. doi: 10.2147/VHRM.S121661. eCollection 2017.
•   Izumi C, Miyake M, Amano M, Kitai T, Obayashi Y, Takegami M, Kimura T, Sugio K, Matsumoto T, Nishimura K, Furukawa Y
  Registry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study. J Card
•   Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L
  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest. 2018 Nov;154(5):1121-1201. doi: 10.
•   Milling TJ Jr, Frontera J
  Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding. Am J Manag Care. 2017 Apr;23(4 Suppl):S67-S80.
•   Miyamoto S, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Murakawa Y, Iwashiro S, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S
  Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrilla
•   Qureshi AI, Mendelow AD, Hanley DF
  Intracerebral haemorrhage. Lancet. 2009 May 9;373(9675):1632-44. doi: 10.1016/S0140-6736(09)60371-8.
•   Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P
  Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospec
•   Roskell NS, Samuel M, Noack H, Monz BU
  Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies. Europace. 2013 Jun;15(6):787-97. doi: 10.1093/europace/eut001. Epub 2
•   Rozjabek HM, Coleman CI, Ashton V, Laliberte F, Oyefesobi P, Lejeune D, Germain G, Schein JR, Yuan Z, Lefebvre P, Peterson ED
  Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral an
•   Ruiz-Sandoval JL, Chiquete E, Garate-Carrillo A, Ochoa-Guzman A, Arauz A, Leon-Jimenez C, Carrillo-Loza K, Murillo-Bonilla LM, Villarreal-Careaga J, Barinagarrementeria F, Cantu-Brito C; RENAMEVASC investigators
  Spontaneous intracerebral hemorrhage in Me
•   You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GYH
  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: Am

Anticoagulant-associated Intracranial Hemorrhage: Patient Characteristics and Outcomes From National Institute of Neurology and Neurosurgery Manuel Velasco: Single-Center Observational Study

Details for clinical trial NCT06168838